Carlos Cordon-Cardo - Publications

Affiliations: 
Genetics and Development Columbia University, New York, NY 
Area:
Genetics, Human Development

161 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kanagasabai T, Li G, Shen TH, Gladoun N, Castillo-Martin M, Celada SI, Xie Y, Brown LK, Mark ZA, Ochieng J, Ballard BR, Cordon-Cardo C, Adunyah SE, Jin R, Matusik RJ, et al. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway. Cancer Letters. PMID 34610416 DOI: 10.1016/j.canlet.2021.09.041  0.303
2020 Wang YA, Sfakianos J, Tewari AK, Cordon-Cardo C, Kyprianou N. Molecular tracing of prostate cancer lethality. Oncogene. PMID 33046797 DOI: 10.1038/s41388-020-01496-5  0.347
2020 Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, et al. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. PMID 32884149 DOI: 10.1038/S41588-020-0701-7  0.381
2020 Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature Genetics. PMID 32820258 DOI: 10.1038/S41588-020-0688-0  0.416
2019 Han D, Rodriguez-Bravo V, Izadmehr S, Domingo-Domenech J, Cordon-Cardo C. Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts. Journal of Visualized Experiments : Jove. PMID 31259909 DOI: 10.3791/57011  0.368
2019 Guarnerio J, Zhang Y, Cheloni G, Panella R, Mae Katon J, Simpson M, Matsumoto A, Papa A, Loretelli C, Petri A, Kauppinen S, Garbutt C, Petur Nielsen G, Deshpande V, Castillo-Martin M, ... Cordon-Cardo C, et al. Intragenic antagonistic roles of protein and circRNA in tumorigenesis. Cell Research. PMID 31209250 DOI: 10.1038/S41422-019-0192-1  0.384
2018 Bodo S, Campagne C, Thin TH, Higginson DS, Vargas HA, Hua G, Fuller JD, Ackerstaff E, Russell J, Zhang Z, Klingler S, Cho H, Kaag MG, Mazaheri Y, Rimner A, ... ... Cordon-Cardo C, et al. Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury. The Journal of Clinical Investigation. PMID 30480549 DOI: 10.1172/Jci97631  0.362
2018 Chen M, Zhang J, Berger AH, Diolombi MS, Ng C, Fung J, Bronson RT, Castillo-Martin M, Thin TH, Cordon-Cardo C, Plevin R, Pandolfi PP. Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis. The Journal of Clinical Investigation. PMID 30475228 DOI: 10.1172/Jci99699  0.309
2018 Smith JT, Wunsch BH, Dogra N, Ahsen ME, Lee K, Yadav KK, Weil R, Pereira MA, Patel JV, Duch EA, Papalia JM, Lofaro MF, Gupta M, Tewari AK, Cordon-Cardo C, et al. Integrated nanoscale deterministic lateral displacement arrays for separation of extracellular vesicles from clinically-relevant volumes of biological samples. Lab On a Chip. PMID 30468237 DOI: 10.1039/C8Lc01017J  0.303
2018 Wang L, Saci A, Szabo PM, Chasalow SD, Castillo-Martin M, Domingo-Domenech J, Siefker-Radtke A, Sharma P, Sfakianos JP, Gong Y, Dominguez-Andres A, Oh WK, Mulholland D, Azrilevich A, Hu L, ... Cordon-Cardo C, et al. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications. 9: 3503. PMID 30158554 DOI: 10.1038/S41467-018-05992-X  0.392
2018 Donovan MJ, Fernandez G, Scott R, Khan FM, Zeineh J, Koll G, Gladoun N, Charytonowicz E, Tewari A, Cordon-Cardo C. Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test. Prostate Cancer and Prostatic Diseases. PMID 30087426 DOI: 10.1038/S41391-018-0067-4  0.399
2018 Lee E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, Wang L, Oh WK, Galsky MD, Cordon-Cardo C, Zhu J. Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR. Oncogene. PMID 29970902 DOI: 10.1038/S41388-018-0367-0  0.418
2018 Neslund-Dudas CM, McBride RB, Kandegedara A, Rybicki BA, Kryvenko ON, Chitale D, Gupta N, Williamson SR, Rogers CG, Cordon-Cardo C, Rundle AG, Levin AM, Dou QP, Mitra B. Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men. Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). 48: 233-238. PMID 29773186 DOI: 10.1016/J.Jtemb.2018.04.006  0.409
2018 Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV, Webster KA, Ng C, Palumbieri MD, Diolombi MS, ... ... Cordon-Cardo C, et al. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nature Genetics. PMID 29335545 DOI: 10.1038/S41588-017-0027-2  0.455
2018 Donovan MJ, Fernandez G, Scott R, Zeineh J, Koll G, Khan F, Gladoun N, Charytonowicz E, Tewari A, Cordon-Cardo C. Abstract B093: Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B093  0.412
2017 Mohr L, Carceles-Cordon M, Woo J, Cordon-Cardo C, Domingo-Domenech J, Rodriguez-Bravo V. Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel. Journal of Visualized Experiments : Jove. PMID 28930981 DOI: 10.3791/56327  0.433
2017 Zabala-Letona A, Arruabarrena-Aristorena A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P, Ximenez-Embun P, Bago R, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, ... ... Cordon-Cardo C, et al. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature. PMID 28658205 DOI: 10.1038/Nature22964  0.419
2017 Kuchay S, Giorgi C, Simoneschi D, Pagan J, Missiroli S, Saraf A, Florens L, Washburn MP, Collazo-Lorduy A, Castillo-Martin M, Cordon-Cardo C, Sebti SM, Pinton P, Pagano M. PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth. Nature. PMID 28614300 DOI: 10.1038/Nature22965  0.312
2017 Han D, Rodriguez-Bravo V, Charytonowicz E, Demicco E, Domingo-Domenech J, Maki RG, Cordon-Cardo C. Targeting sarcoma tumor-initiating cells through differentiation therapy. Stem Cell Research. 21: 117-123. PMID 28433655 DOI: 10.1016/J.Scr.2017.04.004  0.381
2017 Rodriguez-Barrueco R, Nekritz EA, Bertucci F, Yu J, Sanchez-Garcia F, Zeleke TZ, Gorbatenko A, Birnbaum D, Ezhkova E, Cordon-Cardo C, Finetti P, Llobet-Navas D, Silva JM. miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy. Genes & Development. 31: 553-566. PMID 28404630 DOI: 10.1101/Gad.292318.116  0.367
2017 Chen M, Nowak DG, Narula N, Robinson B, Watrud K, Ambrico A, Herzka TM, Zeeman ME, Minderer M, Zheng W, Ebbesen SH, Plafker KS, Stahlhut C, Wang VM, Wills L, ... ... Cordon-Cardo C, et al. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. The Journal of Cell Biology. PMID 28193700 DOI: 10.1083/Jcb.201604025  0.418
2016 Donovan MJ, Cordon-Cardo C. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes. Molecular Diagnosis & Therapy. PMID 28000172 DOI: 10.1007/S40291-016-0249-5  0.327
2016 Rodriguez-Bravo V, Carceles-Cordon M, Hoshida Y, Cordon-Cardo C, Galsky MD, Domingo-Domenech J. The role of GATA2 in lethal prostate cancer aggressiveness. Nature Reviews. Urology. PMID 27872477 DOI: 10.1038/Nrurol.2016.225  0.454
2016 Shukla-Dave A, Castillo-Martin M, Chen M, Lobo J, Gladoun N, Lorduy AC, Khan FM, Ponomarev V, Yi Z, Zhang W, Pandolfi PP, Hricak H, Cordon-Cardo C. Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling. The American Journal of Pathology. PMID 27770613 DOI: 10.1016/J.Ajpath.2016.08.021  0.445
2016 Hu J, Ye F, Cui M, Lee P, Wei C, Hao Y, Wang X, Wang Y, Lu Z, Galsky M, McBride R, Wang L, Wang D, Cordon-Cardo C, Wang C, et al. Protein Profiling of Bladder Urothelial Cell Carcinoma. Plos One. 11: e0161922. PMID 27626805 DOI: 10.1371/Journal.Pone.0161922  0.356
2016 Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, ... ... Cordon-Cardo C, et al. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nature Cell Biology. PMID 27214280 DOI: 10.1038/Ncb3357  0.435
2016 Collazo-Lorduy A, Castillo-Martin M, Wang L, Patel V, Iyer G, Jordan E, Al-Ahmadie H, Leonard I, Oh WK, Zhu J, McBride RB, Cordon-Cardo C, Solit DB, Sfakianos JP, Galsky MD. Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition. European Urology. PMID 27178450 DOI: 10.1016/J.Eururo.2016.04.037  0.374
2016 Grau JJ, Mesía R, de la Iglesia-Vicente M, Williams ES, Taberna M, Caballero M, Larque AB, de la Oliva J, Cordón-Cardo C, Domingo-Domenech J. Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology. PMID 27077749 DOI: 10.1159/000445118  0.364
2016 Castillo-Martin M, Thin TH, Collazo Lorduy A, Cordon-Cardo C. Immunopathologic Assessment of PTEN Expression. Methods in Molecular Biology (Clifton, N.J.). 1388: 23-37. PMID 27033068 DOI: 10.1007/978-1-4939-3299-3_3  0.355
2016 Castillo-Martin M, Collazo Lorduy A, Gladoun N, Hyun G, Cordon-Cardo C. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. Journal of Pediatric Urology. 12: 91.e1-7. PMID 26522772 DOI: 10.1016/J.Jpurol.2015.08.020  0.306
2016 McBride RB, Patel VG, Lorduy AC, Castillo-Martin M, Cha EK, Berger MF, Wang L, Oh WK, Zhu J, Cordon-Cardo C, Solit DB, Sfakianos JP, Galsky MD. Prognostic significance of DNA damage repair (DDR) mutations in patients with urothelial carcinoma (UC) and associations with tumor infiltrating lymphocytes (TILs). Journal of Clinical Oncology. 34: 4538-4538. DOI: 10.1200/Jco.2016.34.15_Suppl.4538  0.342
2016 Lorduy AC, Castillo-Martin M, Lee E, Zhu J, Cordon-Cardo C. Function of microRNA activity by ActMiR in bladder cancer. Journal of Clinical Oncology. 34: 4531-4531. DOI: 10.1200/Jco.2016.34.15_Suppl.4531  0.391
2016 Castillo-Martin M, Gladoun N, Lorduy AC, Gaya J, Algaba F, Redorta JP, Cordon-Cardo C. ΔNp63 is critical for progression of high grade non-muscle invasive bladder cancer through deregulation of specific genetic pathways European Journal of Cancer. 61: S183. DOI: 10.1016/S0959-8049(16)61648-9  0.356
2016 Valcarcel L, Torrano V, Cortazar A, Liu X, Urosevic J, Castillo M, Morciano G, Graupera M, Pandya P, Unda-Urzaiz M, Schultz N, Aransay A, Sanz-Moreno V, Barrio R, Velasco G, ... ... Cordon-Cardo C, et al. Transcriptional regulation of prostate cancer metabolism European Journal of Cancer. 61: S171. DOI: 10.1016/S0959-8049(16)61606-4  0.401
2015 Williams ES, Rodriquez-Bravo V, Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh W, Cordon-Cardo C, Domingo-Domenech J. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Journal of Visualized Experiments : Jove. PMID 26555435 DOI: 10.3791/53182  0.441
2015 Rodriguez-Barrueco R, Yu J, Saucedo-Cuevas LP, Olivan M, Llobet-Navas D, Putcha P, Castro V, Murga-Penas EM, Collazo-Lorduy A, Castillo-Martin M, Alvarez M, Cordon-Cardo C, Kalinsky K, Maurer M, Califano A, et al. Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers. Genes & Development. 29: 1631-48. PMID 26227964 DOI: 10.1101/Gad.262642.115  0.326
2015 Barber AG, Castillo-Martin M, Bonal DM, Jia AJ, Rybicki BA, Christiano AM, Cordon-Cardo C. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer. Cancer Medicine. 4: 1258-71. PMID 26033689 DOI: 10.1002/Cam4.463  0.772
2015 Nowak DG, Cho H, Herzka T, Watrud K, DeMarco DV, Wang VM, Senturk S, Fellmann C, Ding D, Beinortas T, Kleinman D, Chen M, Sordella R, Wilkinson JE, Castillo-Martin M, ... Cordon-Cardo C, et al. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discovery. 5: 636-51. PMID 25829425 DOI: 10.1158/2159-8290.Cd-14-1113  0.443
2015 Puzio-Kuter AM, Laddha SV, Castillo-Martin M, Sun Y, Cordon-Cardo C, Chan CS, Levine AJ. Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. Cell Death and Differentiation. PMID 25822339 DOI: 10.1038/Cdd.2015.27  0.337
2015 Ugalde-Olano A, Egia A, Fernández-Ruiz S, Loizaga-Iriarte A, Zuñiga-García P, Garcia S, Royo F, Lacasa-Viscasillas I, Castro E, Cortazar AR, Zabala-Letona A, Martín-Martín N, Arruabarrena-Aristorena A, Torrano-Moya V, Valcárcel-Jiménez L, et al. Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN. Methods (San Diego, Calif.). 77: 25-30. PMID 25697760 DOI: 10.1016/J.Ymeth.2015.02.005  0.457
2015 Vidal SJ, Rodriguez-Bravo V, Quinn SA, Rodriguez-Barrueco R, Lujambio A, Williams E, Sun X, de la Iglesia-Vicente J, Lee A, Readhead B, Chen X, Galsky M, Esteve B, Petrylak DP, Dudley JT, ... ... Cordon-Cardo C, et al. A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer Cell. 27: 223-39. PMID 25670080 DOI: 10.1016/J.Ccell.2014.11.013  0.431
2015 Lunardi A, Varmeh S, Chen M, Taulli R, Guarnerio J, Ala U, Seitzer N, Ishikawa T, Carver BS, Hobbs RM, Quarantotti V, Ng C, Berger AH, Nardella C, Poliseno L, ... ... Cordon-Cardo C, et al. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. Cancer Discovery. 5: 550-63. PMID 25653093 DOI: 10.1158/2159-8290.Cd-13-1050  0.399
2015 Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs RM, Song MS, Sportoletti P, Bernardi R, Bronson RT, Castillo-Martin M, Cordon-Cardo C, Lunardi A, Pandolfi PP. A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discovery. 5: 396-409. PMID 25614485 DOI: 10.1158/2159-8290.Cd-14-1022  0.31
2015 Epping MT, Lunardi A, Nachmani D, Castillo-Martin M, Thin TH, Cordon-Cardo C, Pandolfi PP. TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation. Cell Death and Differentiation. 22: 1353-62. PMID 25613376 DOI: 10.1038/Cdd.2014.226  0.401
2015 Sia D, Losic B, Moeini A, Cabellos L, Hao K, Revill K, Bonal D, Miltiadous O, Zhang Z, Hoshida Y, Cornella H, Castillo-Martin M, Pinyol R, Kasai Y, Roayaie S, ... ... Cordon-Cardo C, et al. Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nature Communications. 6: 6087. PMID 25608663 DOI: 10.1038/Ncomms7087  0.304
2015 Di Sante G, Pestell TG, Casimiro MC, Bisetto S, Powell MJ, Lisanti MP, Cordon-Cardo C, Castillo-Martin M, Bonal DM, Debattisti V, Chen K, Wang L, He X, McBurney MW, Pestell RG. Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria. The American Journal of Pathology. 185: 266-79. PMID 25529796 DOI: 10.1016/J.Ajpath.2014.09.014  0.415
2015 Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M. ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer. The Journal of Urology. 193: 1144-50. PMID 25444981 DOI: 10.1016/J.Juro.2014.10.098  0.382
2015 Donovan MJ, Khan FM, Scott R, Fernandez G, Cordon-Cardo C. Incorporation of advanced image analysis in novel post-prostatectomy systems pathology models as an approach to replace the clinical Gleason and provide robust risk stratification. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E16134  0.387
2015 Vidal SJ, Rodriguez-Bravo V, Quinn A, Williams E, Iglesia-Vicente Jdl, Sun X, Chen X, Hoshida Y, Cordon-Cardo C, Domingo-Domenech J. Abstract 733: A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer Cancer Research. 75: 733-733. DOI: 10.1158/1538-7445.Am2015-733  0.441
2015 Nowak DG, Cho H, Herzka T, Wang VMY, Senturk S, DeMarco DV, Ding D, Fellmann C, Beinortas T, Kleinman D, Watrud K, Chen M, Wilkinson JE, Castillo-Martin M, Cordon-Cardo C, et al. Abstract 2258: Myc drives Pten/ p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2 Cancer Research. 75: 2258-2258. DOI: 10.1158/1538-7445.Am2015-2258  0.374
2014 Donovan MJ, Cordon-Cardo C. Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers. Expert Review of Molecular Diagnostics. 14: 1023-31. PMID 25327491 DOI: 10.1586/14737159.2014.965151  0.389
2014 Llobet-Navas D, Rodriguez-Barrueco R, de la Iglesia-Vicente J, Olivan M, Castro V, Saucedo-Cuevas L, Marshall N, Putcha P, Castillo-Martin M, Bardot E, Ezhkova E, Iavarone A, Cordon-Cardo C, Silva JM. The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells. Molecular and Cellular Biology. 34: 4216-31. PMID 25266660 DOI: 10.1128/Mcb.00611-14  0.305
2014 Van Batavia J, Yamany T, Molotkov A, Dan H, Mansukhani M, Batourina E, Schneider K, Oyon D, Dunlop M, Wu XR, Cordon-Cardo C, Mendelsohn C. Bladder cancers arise from distinct urothelial sub-populations. Nature Cell Biology. 16: 982-91, 1-5. PMID 25218638 DOI: 10.1038/Ncb3038  0.337
2014 Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, Xu L, Castillo-Martin M, Llobet-Navás D, Cordon-Cardo C, Clappier E, Soulier J, Ferrando AA. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nature Medicine. 20: 1130-7. PMID 25194570 DOI: 10.1038/Nm.3665  0.335
2014 Barber AG, Castillo-Martin M, Bonal DM, Rybicki BA, Christiano AM, Cordon-Cardo C. Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer. Plos One. 9: e98786. PMID 24896103 DOI: 10.1371/Journal.Pone.0098786  0.762
2014 Jia AY, Castillo-Martin M, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C. MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. British Journal of Cancer. 110: 2945-54. PMID 24823697 DOI: 10.1038/Bjc.2014.245  0.72
2014 Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Hall LD, Castillo-Martín M, Fox K, Cordon-Cardo C, Chang R, Sivendran S, Phelps RG, Saenger Y. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma. Journal of the American Academy of Dermatology. 70: 1036-44. PMID 24698703 DOI: 10.1016/J.Jaad.2014.01.914  0.31
2014 Vidal SJ, Quinn SA, de la Iglesia-Vicente J, Bonal DM, Rodriguez-Bravo V, Firpo-Betancourt A, Cordon-Cardo C, Domingo-Domenech J. Isolation of cancer stem cells from human prostate cancer samples. Journal of Visualized Experiments : Jove. PMID 24686446 DOI: 10.3791/51332  0.441
2014 Llobet-Navas D, Rodríguez-Barrueco R, Castro V, Ugalde AP, Sumazin P, Jacob-Sendler D, Demircan B, Castillo-Martín M, Putcha P, Marshall N, Villagrasa P, Chan J, Sanchez-Garcia F, Pe'er D, Rabadán R, et al. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes & Development. 28: 765-82. PMID 24636986 DOI: 10.1101/Gad.237404.114  0.308
2014 Cho H, Herzka T, Zheng W, Qi J, Wilkinson JE, Bradner JE, Robinson BD, Castillo-Martin M, Cordon-Cardo C, Trotman LC. RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis. Cancer Discovery. 4: 318-333. PMID 24444712 DOI: 10.1158/2159-8290.Cd-13-0346  0.456
2014 Vidal SJ, Rodriguez-Bravo V, Galsky M, Cordon-Cardo C, Domingo-Domenech J. Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene. 33: 4451-63. PMID 24096485 DOI: 10.1038/Onc.2013.411  0.339
2014 Khan FM, Fernandez G, Scott R, Lance RS, Cordon-Cardo C, Klotz L, Donovan MJ. A quantitative image analysis model of prostate biopsies for predicting clinical risk in men enrolled in an active surveillance program. Journal of Clinical Oncology. 32: 111-111. DOI: 10.1200/Jco.2014.32.4_Suppl.111  0.377
2014 Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, Xu L, Castillo-Martin M, Llobet-Navas D, Cordon-Cardo C, Clappier E, Soulier J, Ferrando AA. ­­­­­­N-Me, a Long Range T-Cell Specific Oncogenic Enhancer in T-ALL Blood. 124: 487-487. DOI: 10.1182/Blood.V124.21.487.487  0.331
2014 Herranz D, Ambesi-Impiombato A, Sudderth J, Sánchez-Martín M, Tosello V, Xu L, Castillo M, Cordon-Cardo C, Kung AL, DeBerardinis RJ, Ferrando A. Abstract 965: An oncogenic metabolic switch mediates resistance to NOTCH1 inhibition in T-ALL Cancer Research. 74: 965-965. DOI: 10.1158/1538-7445.Am2014-965  0.355
2014 Castillo-Martin M, Gladoun N, Gaya-Sopena JM, Bonal DM, Redorta JP, Cordon-Cardo C. Abstract 436: ΔNp63 is critical for progression of high grade non-muscle invasive bladder cancer to muscle-invasive disease Cancer Research. 74: 436-436. DOI: 10.1158/1538-7445.Am2014-436  0.445
2013 Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, ... ... Cordon-Cardo C, et al. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nature Genetics. 45: 739-46. PMID 23727861 DOI: 10.1038/Ng.2654  0.38
2013 Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. 45: 747-55. PMID 23727860 DOI: 10.1038/Ng.2650  0.446
2013 Guijarro MV, Dahiya S, Danielson LS, Segura MF, Vales-Lara FM, Menendez S, Popiolek D, Mittal K, Wei JJ, Zavadil J, Cordon-Cardo C, Pandolfi PP, Hernando E. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling. The American Journal of Pathology. 182: 2015-27. PMID 23708211 DOI: 10.1016/J.Ajpath.2013.02.035  0.395
2013 Haupt S, Mitchell C, Corneille V, Shortt J, Fox S, Pandolfi PP, Castillo-Martin M, Bonal DM, Cordon-Cardo C, Lozano G, Haupt Y. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle (Georgetown, Tex.). 12: 1722-31. PMID 23656786 DOI: 10.4161/Cc.24805  0.4
2013 Donovan MJ, Cordon-Cardo C. Predicting high-risk disease using tissue biomarkers. Current Opinion in Urology. 23: 245-51. PMID 23478499 DOI: 10.1097/Mou.0B013E32835F89Cc  0.395
2013 Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. The American Journal of Pathology. 182: 1171-9. PMID 23410519 DOI: 10.1016/J.Ajpath.2013.01.006  0.712
2013 Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, Fukunaga-Kanabis M, Perez-Lorenzo R, Zheng B, Silvers DN, Brunner G, Wang S, Rabadan R, Cordon-Cardo C, Celebi JT. GAB2 induces tumor angiogenesis in NRAS-driven melanoma Oncogene. 32: 3627-3637. PMID 22926523 DOI: 10.1038/Onc.2012.367  0.367
2013 Cunningham I, Shiomi T, D'Armiento JM, Rui H, Cordon-Cardo C, Hamele-Bena D. Abstract 1096: Hiding from chemo: Leukemic cells forming tumors to survive. Cancer Research. 73: 1096-1096. DOI: 10.1158/1538-7445.Am2013-1096  0.392
2012 Papa A, Cordon-Cardo C, Bernardi R, Pandolfi PP. Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression. Genes & Cancer. 3: 599-603. PMID 23486996 DOI: 10.1177/1947601912473604  0.336
2012 Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell. 22: 373-88. PMID 22975379 DOI: 10.1016/J.Ccr.2012.07.016  0.456
2012 Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Davé UP, Ferrando A, Lannutti BJ, Diacovo TG. Targeting Nonclassical Oncogenes for Therapy in T-ALL Cancer Cell. 21: 459-472. PMID 22516257 DOI: 10.1016/J.Ccr.2012.02.029  0.322
2012 Samon JB, Castillo-Martin M, Hadler M, Ambesi-Impiobato A, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Jakubczak J, Randolph S, Cordon-Cardo C, Ferrando AA. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia. Molecular Cancer Therapeutics. 11: 1565-75. PMID 22504949 DOI: 10.1158/1535-7163.Mct-11-0938  0.312
2012 Shen TH, Gladoun N, Castillo-Martin M, Bonal D, Domingo-Domenech J, Charytonowicz D, Cordon-Cardo C. A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium. Plos One. 7: e35243. PMID 22496911 DOI: 10.1371/Journal.Pone.0035243  0.301
2012 Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. The American Journal of Pathology. 180: 1808-15. PMID 22426337 DOI: 10.1016/J.Ajpath.2012.01.034  0.719
2012 Donovan MJ, Khan FM, Bayer-Zubek V, Powell D, Costa J, Cordon-Cardo C. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer. Bju International. 109: 207-13. PMID 21733075 DOI: 10.1111/J.1464-410X.2011.10316.X  0.421
2012 Kim IY, Yan X, Tohme S, Ahmed A, Cordon-Cardo C, Shantha Kumara HM, Kim SK, Whelan RL. CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model. The Journal of Surgical Research. 174: 284-90. PMID 21324492 DOI: 10.1016/J.Jss.2010.12.021  0.302
2012 Herranz D, Tosello V, Ambesi-Impiombato A, Castillo M, Cordon-Cardo C, Ferrando AA. An Oncogenic Metabolic Switch Mediates Resistance to NOTCH1 Inhibition in T-ALL Blood. 120: 285-285. DOI: 10.1182/Blood.V120.21.285.285  0.382
2012 Diacovo T, Whye D, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Dave UP, Ferrando AA, Lannutti BJ, Subramaniam P. Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival Blood. 120: 1492-1492. DOI: 10.1182/Blood.V120.21.1492.1492  0.385
2012 McBride RB, Cordon-Cardo C, Rybicki BA. Abstract A08: Race and aggressive prostate cancer: Resolving bias introduced by treatment selection. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A08  0.379
2011 Samon JB, Castillo-Martin M, Jakubczak JL, Randolph S, Cordon-Cardo C, Ferrando AA. Reversal of glucocorticoid resistance by the g-secretase inhibitor PF-03084014 in T-cell acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9553. PMID 28019758 DOI: 10.1200/Jco.2011.29.15_Suppl.9553  0.305
2011 Donovan MJ, Costa J, Cordon-Cardo C. Personalized approach to prostate cancer prognosis. Archivos EspañOles De UrologíA. 64: 783-91. PMID 22052759  0.334
2011 Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylack DP, Benson MC, McKiernan JM, Cordon-Cardo C. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy. The Journal of Urology. 186: 2094-100. PMID 21944130 DOI: 10.1016/J.Juro.2011.06.051  0.347
2011 Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O'Neill A, Castillo-Martin M, Nowak DG, Naguib A, Grace DM, Murn J, Navin N, Atwal GS, Sander C, Gerald WL, ... Cordon-Cardo C, et al. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell. 20: 173-86. PMID 21840483 DOI: 10.1016/J.Ccr.2011.07.013  0.468
2011 Karni-Schmidt O, Castillo-Martin M, Shen TH, HuaiShen T, Gladoun N, Domingo-Domenech J, Sanchez-Carbayo M, Li Y, Lowe S, Prives C, Cordon-Cardo C. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. The American Journal of Pathology. 178: 1350-60. PMID 21356385 DOI: 10.1016/J.Ajpath.2010.11.061  0.381
2011 Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow WS, Wang C, McCue PA, McBurney MW, Pestell RG. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Cancer Research. 71: 964-75. PMID 21189328 DOI: 10.1158/0008-5472.Can-10-3172  0.312
2011 Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O'Neill A, Castillo-Martin M, Nowak DG, Naguib A, Grace DM, Murn J, Sander C, Gerald WL, Cordon-Cardo C, Newton AC, et al. Abstract 2405: Identification of PHLPP as a tumour suppressor reveals the role of pathway feedback compensation in PTEN-mutant prostate cancer progression Cancer Research. 71: 2405-2405. DOI: 10.1158/1538-7445.Am2011-2405  0.466
2010 De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, ... ... Cordon-Cardo C, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature Medicine. 16: 1321-7. PMID 20972433 DOI: 10.1038/Nm.2246  0.348
2010 Harris CR, Normart R, Yang Q, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ, Tang LH. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes & Cancer. 1: 115-24. PMID 20948976 DOI: 10.1177/1947601909360812  0.365
2010 Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C. Molecular pathways of urothelial development and bladder tumorigenesis. Urologic Oncology. 28: 401-8. PMID 20610278 DOI: 10.1016/J.Urolonc.2009.04.019  0.454
2010 Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, Scott KL, Kwong LN, Xiao Y, Cordon-Cardo C, Granter SR, Ramaswamy S, Golub T, Duncan LM, Wagner SN, et al. Integrative genome comparison of primary and metastatic melanomas. Plos One. 5: e10770. PMID 20520718 DOI: 10.1371/Journal.Pone.0010770  0.33
2010 Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, et al. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis. 31: 1264-71. PMID 20478923 DOI: 10.1093/Carcin/Bgq096  0.309
2010 Canesin G, Gonzalez-Peramato P, Palou J, Urrutia M, Cordón-Cardo C, Sánchez-Carbayo M. Galectin-3 expression is associated with bladder cancer progression and clinical outcome. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 31: 277-85. PMID 20401558 DOI: 10.1007/s13277-010-0033-9  0.33
2010 Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, De Moerloose B, Philippé J, González-García S, Toribio ML, Taghon T, Zuurbier L, Cauwelier B, Harrison CJ, Schwab C, ... ... Cordon-Cardo C, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genetics. 42: 338-42. PMID 20228800 DOI: 10.1038/Ng.542  0.328
2010 Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, et al. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. International Journal of Cancer. Journal International Du Cancer. 127: 2169-82. PMID 20112337 DOI: 10.1002/Ijc.25214  0.3
2010 Yoshizawa A, Fukuoka J, Shimizu S, Shilo K, Franks TJ, Hewitt SM, Fujii T, Cordon-Cardo C, Jen J, Travis WD. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 240-8. PMID 20008839 DOI: 10.1158/1078-0432.Ccr-09-0986  0.319
2010 Donovan MJ, Osman I, Khan FM, Vengrenyuk Y, Capodieci P, Koscuiszka M, Anand A, Cordon-Cardo C, Costa J, Scher HI. Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease Bju International. 105: 462-467. PMID 19624594 DOI: 10.1111/J.1464-410X.2009.08747.X  0.446
2010 De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan P, Kelliher M, Kee BL, ... ... Cordon-Cardo C, et al. BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia Blood. 116: 471-471. DOI: 10.1182/Blood.V116.21.471.471  0.335
2009 Donovan MJ, Khan F, Powell D, Capodieci P, Gleave M, Taylor I, Gomez-Navarro J, Cordon-Cardo C. Characterization of lymphoid infiltrates in prostatectomy specimens post neoadjuvant hormonal therapy using quantitative immunofluorescence and RNA FISH. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16104. PMID 27963334 DOI: 10.1200/Jco.2009.27.15_Suppl.E16104  0.338
2009 Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, Abate-Shen C. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prevention Research (Philadelphia, Pa.). 2: 1008-14. PMID 19952358 DOI: 10.1158/1940-6207.Capr-09-0169  0.403
2009 Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, ... ... Cordon-Cardo C, et al. 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Research. 69: 6299-306. PMID 19602588 DOI: 10.1158/0008-5472.Can-09-0820  0.367
2009 Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y, Castro V, Bonilla F, Cordon-Cardo C, Muthuswamy SK, Powers S, Fuchs E, Hannon GJ. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell. 137: 1047-61. PMID 19524508 DOI: 10.1016/J.Cell.2009.04.013  0.417
2009 Donovan MJ, Khan FM, Fernandez G, Mesa-Tejada R, Sapir M, Zubek VB, Powell D, Fogarasi S, Vengrenyuk Y, Teverovskiy M, Segal MR, Karnes RJ, Gaffey TA, Busch C, Haggman M, ... ... Cordon-Cardo C, et al. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. The Journal of Urology. 182: 125-32. PMID 19450827 DOI: 10.1016/J.Juro.2009.02.135  0.417
2009 Hernando E, Sarmentero-Estrada J, Koppie T, Belda-Iniesta C, Ramírez de Molina V, Cejas P, Ozu C, Le C, Sánchez JJ, González-Barón M, Koutcher J, Cordón-Cardó C, Bochner BH, Lacal JC, Ramírez de Molina A. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene. 28: 2425-35. PMID 19448670 DOI: 10.1038/Onc.2009.91  0.423
2009 Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature Genetics. 41: 619-24. PMID 19396168 DOI: 10.1038/Ng.370  0.465
2009 Donovan MJ, Kotsianti A, Bayer-Zubek V, Verbel D, Teverovskiy M, Cordon-Cardo C, Costa J, Greco FA, Hainsworth JD, Parums DV. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. European Journal of Cancer (Oxford, England : 1990). 45: 1518-26. PMID 19272767 DOI: 10.1016/J.Ejca.2009.02.004  0.321
2009 Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, Shen MM, Cordon-Cardo C, Abate-Shen C. Inactivation of p53 and Pten promotes invasive bladder cancer. Genes & Development. 23: 675-80. PMID 19261747 DOI: 10.1101/Gad.1772909  0.305
2009 Carver BS, Tran J, Chen Z, Carracedo-Perez A, Alimonti A, Nardella C, Gopalan A, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. ETS rearrangements and prostate cancer initiation. Nature. 457: E1; discussion E2-3. PMID 19212347 DOI: 10.1038/Nature07738  0.391
2009 Nardella C, Carracedo A, Alimonti A, Hobbs RM, Clohessy JG, Chen Z, Egia A, Fornari A, Fiorentino M, Loda M, Kozma SC, Thomas G, Cordon-Cardo C, Pandolfi PP. Differential requirement of mTOR in postmitotic tissues and tumorigenesis. Science Signaling. 2: ra2. PMID 19176516 DOI: 10.1126/Scisignal.2000189  0.442
2009 Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E, Sulis ML, Barnes K, Sawai C, Homminga I, Meijerink J, Aifantis I, Basso G, Cordon-Cardo C, Ai W, et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nature Medicine. 15: 50-8. PMID 19098907 DOI: 10.1038/Nm.1900  0.313
2009 Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Letters. 279: 126-36. PMID 19008039 DOI: 10.1016/J.Canlet.2008.09.039  0.326
2009 Mendez N, Orenes-Piñero E, Gaspar M, Fierro M, Ecke T, Gil M, Palou J, Bellmunt J, Cordon-Cardo C, Lopez-Beltran A, Sanchez-Carbayo M. DISCOVERY OF THE METHYLATION OF THE METASTASIS SUPPRESSOR GENE, KISS-1, IN BLADDER CANCER Journal of Urology. 181: 374-374. DOI: 10.1200/Jco.2009.27.15_Suppl.5023  0.333
2009 De Keersmaecker K, Luna PJR, Gatta GD, Palomero T, Castillo M, Sulis ML, Tosello V, Gounari F, Kee B, Lenz J, Kelliher M, Aplan PD, Cordon-Cardo C, Ferrando AA. The HOX11/TLX1 Transcription Factor Oncogene Induces Chromosomal Aneuploidy in T-ALL. Blood. 114: 142-142. DOI: 10.1182/Blood.V114.22.142.142  0.346
2008 Donovan MJ, Mesa-Tejada R, Teverovskiy M, Khan F, Gaffey T, Karnes RJ, Busch C, Haggmanm M, Freedland S, Albertsen PC, Cordon-Cardo C. A systems pathology approach to predict prostate cancer progression, post radical prostatectomy, at the time of diagnosis: Interim results from a multi-center study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5062. PMID 27948785 DOI: 10.1200/Jco.2008.26.15_Suppl.5062  0.406
2008 Cordon-Cardo C. Molecular alterations associated with bladder cancer initiation and progression. Scandinavian Journal of Urology and Nephrology. Supplementum. 154-65. PMID 18815930 DOI: 10.1080/03008880802291915  0.311
2008 Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. The Journal of Clinical Investigation. 118: 3051-64. PMID 18725989 DOI: 10.1172/Jci34764  0.349
2008 Donovan MJ, Hamann S, Clayton M, Khan FM, Sapir M, Bayer-Zubek V, Fernandez G, Mesa-Tejada R, Teverovskiy M, Reuter VE, Scardino PT, Cordon-Cardo C. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3923-9. PMID 18711180 DOI: 10.1200/JCO.2007.15.3155  0.315
2008 Nardella C, Chen Z, Salmena L, Carracedo A, Alimonti A, Egia A, Carver B, Gerald W, Cordon-Cardo C, Pandolfi PP. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. Genes & Development. 22: 2172-7. PMID 18708577 DOI: 10.1101/Gad.1699608  0.329
2008 Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Research. 68: 2241-9. PMID 18381430 DOI: 10.1158/0008-5472.Can-07-6350  0.348
2008 Matushansky I, Hernando E, Socci ND, Matos T, Mills J, Edgar MA, Schwartz GK, Singer S, Cordon-Cardo C, Maki RG. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. The American Journal of Pathology. 172: 1069-80. PMID 18310505 DOI: 10.2353/Ajpath.2008.070284  0.324
2008 Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Research. 68: 1197-203. PMID 18281496 DOI: 10.1158/0008-5472.Can-07-5163  0.329
2007 Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, ... Cordon-Cardo C, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nature Medicine. 13: 1203-10. PMID 17873882 DOI: 10.1038/Nm1636  0.33
2007 Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Research. 67: 7106-12. PMID 17671177 DOI: 10.1158/0008-5472.Can-06-4798  0.355
2007 Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, et al. Improved prediction of prostate cancer recurrence through systems pathology. The Journal of Clinical Investigation. 117: 1876-83. PMID 17557117 DOI: 10.1172/Jci31399  0.316
2007 Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, Pandolfi PP, Cordon-Cardo C. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nature Medicine. 13: 748-53. PMID 17496901 DOI: 10.1038/Nm1560  0.321
2007 Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, et al. Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression Cell. 128: 141-156. PMID 17218261 DOI: 10.1016/J.Cell.2006.11.040  0.303
2007 Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 128: 129-39. PMID 17218260 DOI: 10.1016/J.Cell.2006.11.039  0.338
2007 Cordon-Cardo C, Donovan MJ, Khan F, Teverovskiy M, Hamann S, Eggener S, Vicars A, Scardino P. Androgen receptor (AR) level in the prostatectomy specimen predicts time to disease progression post androgen suppression therapy Journal of Clinical Oncology. 25: 5065-5065. DOI: 10.1200/Jco.2007.25.18_Suppl.5065  0.361
2007 Real PJ, Tosello V, Ai W, Palomero T, Sulis ML, Castillo M, Homminga I, Meijerink J, Cordon-Cardo C, Ferrando A. Inhibition of NOTCH1 Signaling Reverses Glucocorticoid Resistance in T-ALL. Blood. 110: 151-151. DOI: 10.1182/Blood.V110.11.151.151  0.317
2006 Donovan MJ, Scher H, Scardino P, Kotsianti A, Cordon-Cardo C. Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment Journal of Clinical Oncology. 24: 4504-4504. DOI: 10.1200/Jco.2006.24.18_Suppl.4504  0.417
2006 Cordon-Cardo C, Donovan MJ, Kotsianti A, Capodieci P, Jeffers Y, Verbel D, Kahn F, Saidi O, Reuter VE, Gerald W, Bianco FJ, Scardino PT. 818: Protein Expression Profiles for JAG-1 and NFK-B Suggest Converging Roles in Prostate Cancer Progression Journal of Urology. 175: 264-264. DOI: 10.1016/S0022-5347(18)33054-4  0.312
2005 Donovan MJ, Kotsianti A, Colomer A, Verdu M, Clayton M, Pang H, Hamann S, Cordon-Cardo C, Puig X. Diagnostic sub-classification of non-small cell lung cancer: Importance in clinical therapeutics and prognostication. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9597. PMID 27944082 DOI: 10.1200/Jco.2005.23.16_Suppl.9597  0.318
2005 Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harbor Symposia On Quantitative Biology. 70: 251-61. PMID 16869761 DOI: 10.1101/Sqb.2005.70.059  0.332
2005 Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 436: 725-30. PMID 16079851 DOI: 10.1038/Nature03918  0.353
2005 Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C, Gonen M, Schwartz GK. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3296-302. PMID 15867226 DOI: 10.1158/1078-0432.CCR-04-2417  0.312
2004 Cordon-Cardo C, Kotsianti A, Donovan MJ, Capodieci P, Verbel DA, Teverovskiy M, Saidi O, Edelson J, Wheeler TM, Ayala G. Improved prediction of PSA recurrence through systems pathology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4591. PMID 28015983 DOI: 10.1200/Jco.2004.22.14_Suppl.4591  0.3
2004 Afar DE, Bhaskar V, Ibsen E, Breinberg D, Henshall SM, Kench JG, Drobnjak M, Powers R, Wong M, Evangelista F, O'Hara C, Powers D, DuBridge RB, Caras I, Winter R, ... ... Cordon-Cardo C, et al. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Molecular Cancer Therapeutics. 3: 921-32. PMID 15299075  0.344
2004 Mao GE, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, DeKernion JB, Zhang ZF, Rao J. Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 383-90. PMID 15006913  0.32
2004 Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. Journal of the National Cancer Institute. 96: 269-79. PMID 14970276 DOI: 10.1093/Jnci/Djh043  0.397
2003 Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. Pten dose dictates cancer progression in the prostate. Plos Biology. 1: E59. PMID 14691534 DOI: 10.1371/Journal.Pbio.0000059  0.347
2003 Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P. Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene. 22: 5298-305. PMID 12917631 DOI: 10.1038/Sj.Onc.1206616  0.329
2003 Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, Woodruff JM, Lewis JJ, Brennan MF, Houghton AN, Cordon-Cardo C. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. The American Journal of Pathology. 163: 691-700. PMID 12875988 DOI: 10.1016/S0002-9440(10)63696-6  0.328
2003 Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, Zeleniuch-Jacquotte A, Polsky D, Ferrara J, Perez-Soler R, Cordon-Cardo C, Pagano M, Osman I. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 2613-9. PMID 12855638  0.319
2003 Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. The American Journal of Pathology. 162: 609-17. PMID 12547718 DOI: 10.1016/S0002-9440(10)63854-0  0.337
2002 Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Research. 62: 6973-80. PMID 12460915  0.314
2001 Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, Broxmeyer HE, Hromas R, Pandolfi PP. Mzf1 controls cell proliferation and tumorigenesis. Genes & Development. 15: 1625-30. PMID 11445537 DOI: 10.1101/Gad.902301  0.338
2001 Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, P Pandolfi P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse Nature Genetics. 27: 222-224. PMID 11175795 DOI: 10.1038/84879  0.39
2001 Morris M, Tong W, Cordon-Cardo C, Drobnjak M, Kelly W, Slovin S, Rosen N, Scher H. BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer European Journal of Cancer. 37: S218-S219. DOI: 10.1016/S0959-8049(01)81293-4  0.407
2000 Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Histology and Histopathology. 15: 365-74. PMID 10809354 DOI: 10.14670/HH-15.365  0.312
2000 Rabbani F, Cordon-Cardo C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. The Urologic Clinics of North America. 27: 83-102, ix. PMID 10696248 DOI: 10.1016/S0094-0143(05)70237-8  0.309
1999 Agus DB, Cordon-Cardo C, William F, Drobnjak M, Koff A, Golde DW, Scher HI. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence Journal of the National Cancer Institute. 91: 1869-1876. PMID 10547394 DOI: 10.1093/Jnci/91.21.1869  0.34
1998 Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. Journal of the National Cancer Institute. 90: 1284-91. PMID 9731735 DOI: 10.1093/Jnci/90.17.1284  0.329
1996 Lacombe L, Orlow I, Reuter VE, Fair WR, Dalbagni G, Zhang ZF, Cordon-Cardo C. Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. International Journal of Cancer. 69: 110-3. PMID 8608977 DOI: 10.1002/(Sici)1097-0215(19960422)69:2<110::Aid-Ijc7>3.0.Co;2-3  0.311
1995 Dalbagni G, Cordon-Cardo C, Reuter V, Fair WR. Tumor Suppressor Gene Alterations in Bladder Carcinoma Surgical Oncology Clinics of North America. 4: 231-240. DOI: 10.1016/S1055-3207(18)30450-2  0.337
1994 Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C. Immunohistochemical determination of P53 protein nuclear accumulation in prostatic adenocarcinoma Journal of Urology. 151: 1276-1280. PMID 8158773 DOI: 10.1016/S0022-5347(17)35231-X  0.302
1994 Zeng Z, Sarkis AS, Zhang Z, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM. p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. Journal of Clinical Oncology. 12: 2043-2050. PMID 7931472 DOI: 10.1200/Jco.1994.12.10.2043  0.363
1992 Cordon-cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer Journal of the National Cancer Institute. 84: 1251-1256. PMID 1640484 DOI: 10.1093/jnci/84.16.1251  0.312
Show low-probability matches.